BrickBio

BrickBio is a preclinical-stage biopharmaceutical company developing precision biologics using an expanded genetic code. Their technology incorporates synthetic amino acids into proteins within a living cell, enabling the creation of novel therapeutics for antibody-drug conjugates (ADCs), AAV gene therapy, and other modalities. This innovative approach offers potential solutions for challenging medical conditions.

Buy Funded Startups lists

Funding Round:

Funding Amount:

Date: 18-Mar-2024

Investors: Samsung Ventures

Markets: Biotechnology, Biopharmaceuticals, Protein Engineering, Drug Discovery, HealthTech, Life Sciences

HQ: Waltham, Massachusetts, United States

Founded: 2019

Website: https://www.brickbio.com/

LinkedIn: https://www.linkedin.com/company/brickbio

Twitter:

Instagram: